Too Low the price than the rea

Like
Comment
Favorite

Annalz
2022-09-14

Too Low the price than the real value

After-Hours Movers: Starbucks, Flowserve, Conformis And More

After-Hours Stock Movers:Conformis, Inc. 9% HIGHER; announced that it has received 510(k) clearance

After-Hours Movers: Starbucks, Flowserve, Conformis And More

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":9935460721,"tweetId":"9935460721","gmtCreate":1663122599063,"gmtModify":1676537208901,"author":{"id":3577089953267281,"idStr":"3577089953267281","authorId":3577089953267281,"authorIdStr":"3577089953267281","name":"Annalz","avatar":"https://static.tigerbbs.com/ffd285ab6189bb61da4b48c3e149eedc","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":51,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>Too Low the price than the real value&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Too Low the price than the real value&nbsp;</p></body></html>","text":"Too Low the price than the real value","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/9935460721","repostId":2267850566,"repostType":4,"repost":{"id":"2267850566","kind":"highlight","pubTimestamp":1663111803,"share":"https://www.laohu8.com/m/news/2267850566?lang=&edition=full","pubTime":"2022-09-14 07:30","market":"us","language":"en","title":"After-Hours Movers: Starbucks, Flowserve, Conformis And More","url":"https://stock-news.laohu8.com/highlight/detail?id=2267850566","media":"StreetInsider","summary":"After-Hours Stock Movers:Conformis, Inc.  9% HIGHER; announced that it has received 510(k) clearance","content":"<html><head></head><body><p><b>After-Hours Stock Movers:</b></p><p><a href=\"https://laohu8.com/S/CFMS\">Conformis, Inc. </a> 9% HIGHER; announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for the Companys Actera Hip System.</p><p><a href=\"https://laohu8.com/S/PNT\">POINT Biopharma Global Inc. </a> 8% LOWER; announced that it has commenced an underwritten public offering of its common stock.</p><p><a href=\"https://laohu8.com/S/SBUX\">Starbucks </a> 3% HIGHER; sees 15-20% adjusted EPS growth in FY23-FY25</p><p><a href=\"https://laohu8.com/S/FLS\">Flowserve Corporation </a> 2% LOWER; said per events are expected to negatively impact our reported and adjusted EPS by 18 to 22 cents in the 2022 third quarter.</p><p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics, Inc. </a> 1% LOWER; commenced an underwritten public offering of $175.0 million of shares of its common stock.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Movers: Starbucks, Flowserve, Conformis And More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Movers: Starbucks, Flowserve, Conformis And More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-14 07:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=20581805><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Conformis, Inc.  9% HIGHER; announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for the Companys Actera Hip System.POINT Biopharma ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20581805\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SBUX":"星巴克","CFMS":"ConforMIS, Inc.","PNT":"POINT BIOPHARMA GLOBAL INC"},"source_url":"https://www.streetinsider.com/dr/news.php?id=20581805","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2267850566","content_text":"After-Hours Stock Movers:Conformis, Inc.  9% HIGHER; announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for the Companys Actera Hip System.POINT Biopharma Global Inc.  8% LOWER; announced that it has commenced an underwritten public offering of its common stock.Starbucks  3% HIGHER; sees 15-20% adjusted EPS growth in FY23-FY25Flowserve Corporation  2% LOWER; said per events are expected to negatively impact our reported and adjusted EPS by 18 to 22 cents in the 2022 third quarter.Akero Therapeutics, Inc.  1% LOWER; commenced an underwritten public offering of $175.0 million of shares of its common stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":308,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":30,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}